Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Who is Sukumara Kurup? Here is why Keralam’s most infamous fugitive is back in the news after four decades

Keralam Home Minister Ramesh Chennithala has directed the Crime Branch to verify reports about fugitive Sukumara Kurup being alive. There are rumors he lives under a false identity in a foreign country, but Chennithala emphasized the need for factual investigation over speculation.

Who is Sukumara Kurup? Here is why Keralam’s most infamous fugitive is back in the news after four decades

Keralam's most infamous fugitive, Sukumara Kurup, is back in the news after four decades following rumors of his alleged survival. Home Minister Ramesh Chennithala has instructed the state Crime Branch to verify media reports regarding Kurup's current status. The Kerala Police are now reaching out to Interpol to uncover the truth behind the rumors.

Kurup, whose real name is Gopalakrishna Kurup, is believed to be living in a foreign country under a false identity. Born in Alappuzha, Kurup was a former Indian Air Force airman who became Kerala's most wanted fugitive after murdering a stranger and burning his body inside his car to claim an insurance payout. The murder took place in January 1984, and while the initial investigation ruled it as an accident, subsequent investigations revealed the truth.

Kurup has not been seen since his disappearance in 1984, but people have claimed to have seen him in various places over the years. In 2021, a Malayalam film titled "Kurup" brought his real-life crime story back to the forefront of public attention. Recently, Ali Akbar, a former Crime Branch official, claimed that Kurup was living in Brunei under the false identity of John Menon.

Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at livemint.com →

More in Finance & Markets

Samsung Biologics Raises $2.18 Billion to Expand Into Peptides

Samsung Biologics said its board approved a 3 trillion-won ($2.18 billion) capital increase on Aug. 28 to expand its presence in the global peptide drug market and increase production capacity.

  • Samsung Biologics raises $2.18 billion for peptide drug market expansion
  • Funds allocated for PolyPeptide Group acquisition and Songdo facility expansion
  • Plans to build six 180,000-liter capacity plants by 2032

China's yuan steady as US monetary policy in focus

SHANGHAI: [China’s yuan held steady on Friday]( https://China ’s yuan steady as US monetary policy in focus), hovering around its strongest against the dollar in 3-1/2 years, as traders watch for fresh cues of future US monetary policies.

More from Friday 28 August →